logo
welcome
Reuters

Reuters

US minority veterans face unequal access to Ozempic and Wegovy, study finds

Reuters
Summary
Nutrition label

81% Informative

U.S. military veterans face inequities in access to Novo Nordisk's drugs for diabetes and weight loss.

Black patients and those of Asian or Native American ancestry were less likely to receive semaglutide than white patients for diabetes or weight loss, study leader Dr. Rebecca Tisdale says.

VR Score

91

Informative language

98

Neutral language

54

Article tone

formal

Language

English

Language complexity

71

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links